HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins.
Li J, Tang X, Xu J, Liu R, Jiang L, Xu L, Tian J, Feng X, Wu Y, Zhang Y, Wang D, Sun K, Xu B, Zhao W, Hui R, Gao R, Song L, Yuan J, Zhao X.
Li J, et al. Among authors: hui r.
BMC Cardiovasc Disord. 2023 Jun 24;23(1):317. doi: 10.1186/s12872-023-03285-w.
BMC Cardiovasc Disord. 2023.
PMID: 37355634
Free PMC article.